Mimedx (MDXG) Liabilities from Discontinued Operations (2022 - 2024)

Mimedx has disclosed Liabilities from Discontinued Operations across 3 years of filings, most recently posting $217000.0 for Q2 2024.

• In Q2 2024, Liabilities from Discontinued Operations changed N/A year-over-year to $217000.0; the TTM figure through Jun 2024 stood at $217000.0 (changed N/A YoY), while the FY2023 annual figure was $1.4 million, down 8.59% from the prior year.
• Liabilities from Discontinued Operations came in at $217000.0 for Q2 2024 at Mimedx, down from $344000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of $1.5 million in Q4 2022 to a low of $217000.0 in Q2 2024.
• Average Liabilities from Discontinued Operations over 3 years is $848000.0, with a median of $848000.0 recorded in 2023.
• The largest YoY upside for Liabilities from Discontinued Operations was 8.59% in 2023 against a maximum downside of 8.59% in 2023.
• Over 3 years, Liabilities from Discontinued Operations stood at $1.5 million in 2022, then retreated by 8.59% to $1.4 million in 2023, then plunged by 83.95% to $217000.0 in 2024.
• Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were $217000.0 in Q2 2024, $344000.0 in Q1 2024, and $1.4 million in Q4 2023.